Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GS1-279B7.1, also named "microtubule associated protein 1 light chain 3 beta pseudogene," is a human pseudogene, meaning it resembles the sequence of the protein-coding MAP1LC3B gene but does not encode a functional protein product[2]. Pseudogenes in general may be used as RNA transcripts with regulatory potential, including acting as decoys for microRNAs or affecting the regulation of their parent genes, but there is no established druggability, biological function, or interaction information for this specific pseudogene. The functional MAP1LC3B protein, by contrast, plays important roles in autophagy and neurogenesis, and is implicated in disease states such as cancer and metabolic disorders, but GS1-279B7.1 does not share these functions[1][2]. GS1-279B7.1 is not a protein or drug target, but a pseudogene; there is no evidence for therapeutic relevance, known function, or druggability for this entity[2][4]. For therapeutic or biological activity relevant to autophagy and microtubule function, the protein-coding MAP1LC3B gene (not the pseudogene) is the relevant entity[1][3].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule associated protein 1 light chain 3 beta pseudogene (GS1-279B7.1).